Yellow fever vaccination: estimating coverage

The Lancet Infectious Diseases

Volumn 17, Issue 11, 2017, Pages 1109-1111

  Wilder Smith, Annelies ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VACCINE;

GLOBAL DISEASE BURDEN; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; NOTE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SURGE CAPACITY; VACCINATION; WORLD HEALTH ORGANIZATION; YELLOW FEVER; EPIDEMIC;

DISEASE OUTBREAKS; HUMANS; VACCINATION; YELLOW FEVER; YELLOW FEVER VACCINE;

EID: 85027512330     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(17)30494-2     Document Type: Note

References (16)

1. Wilder-Smith, A, Gubler, DJ, Weaver, SC, Monath, TP, Heymann, DL, Scott, TW, Epidemic arboviral diseases: priorities for research and public health. Lancet Infect Dis 17 (2017), e101–e106.
2. Kraemer, MU, Faria, NR, Reiner, RC Jr, et al. Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study. Lancet Infect Dis 17 (2017), 330–338.
3. Wilder-Smith, A, Leong, WY, Importation of yellow fever into China: assessing travel patterns. J Travel Med, 24, 2017, 4.
4. Couto-Lima, D, Madec, Y, Bersot, MI, et al. Potential risk of re-emergence of urban transmission of Yellow Fever virus in Brazil facilitated by competent Aedes populations. Sci Rep, 7, 2017, 4848.
5. Wilder-Smith, A, Monath, TP, Responding to the threat of urban yellow fever outbreaks. Lancet Infect Dis 17 (2017), 248–250.
6. WHO. Global strategy to eliminate yellow fever epidemics (EYE), 2016, World Health Organization, Geneva.
7. Shearer, FM, Moyes, CL, Pigott, DM, et al. Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis. Lancet Infect Dis, 2017 published online Aug 16. http://dx.doi.org/10.1016/S1473-3099(17)30419-X.
8. Jentes, ES, Poumerol, G, Gershman, MD, et al. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. Lancet Infect Dis 11 (2011), 622–632.
9. Monath, TP, Woodall, JP, Gubler, DJ, et al. Yellow fever vaccine supply: a possible solution. Lancet 387 (2016), 1599–1600.
10. Barrett, AD, Yellow fever in Angola and beyond—the problem of vaccine supply and demand. N Engl J Med 375 (2016), 301–303.
11. Glaesser, D, Kester, J, Paulose, H, Alizadeh, A, Valentin, B, Global travel patterns: an overview. J Travel Med, 24, 2017, 4.
12. Schonenberger, S, Hatz, C, Buhler, S, Unpredictable checks of yellow fever vaccination certificates upon arrival in Tanzania. J Travel Med, 23, 2016, 5.
13. Monath, TP, Gershman, M, Hill, DR, Marano, N, Staples, JE, Wilder-Smith, A, Yellow fever recommendations for tourists to Kenya: a flawed risk assessment. J Travel Med, 16, 2009, 146.
14. Boubaker, R, Meige, P, Mialet, C, et al. Travellers' profile, travel patterns and vaccine practices–a 10-year prospective study in a Swiss Travel Clinic. J Travel Med, 23, 2016, 1.
15. Wilder-Smith, A, Khairullah, NS, Song, JH, Chen, CY, Torresi, J, Travel health knowledge, attitudes and practices among Australasian travelers. J Travel Med 11 (2004), 9–15.
16. Leder, K, Borwein, S, Chanthavanich, P, et al. Travel medicine perspectives of select travel medicine experts practicing in the Asia-Pacific region. J Travel Med, 24, 2017, 4.